Bay City Capital

Bay City Capital

Bay City Capital

Follow us
Alexa global traffic share
Latest investments Show all
$100,500,000
Venture capital (Series B)
Akrevia Therapeutics, Inc.
$20,300,000
Venture capital (Series B)
Oculis
Team Size
1–10
Employees
Markets focus
Past year's investments

Bay City Capital participated in fewer than 3 rounds over the past year

Latest rounds
  • Akrevia Therapeutics, Inc.: Venture capital (Series B) ($100.5M)
  • Oculis: Venture capital (Series B) ($20.3M)
  • Kezar Life Sciences: Venture capital (Series B) ($50M)